These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31773862)

  • 1. Effect of vitamin D on cognitive function and white matter hyperintensity in patients with mild Alzheimer's disease.
    Shih EJ; Lee WJ; Hsu JL; Wang SJ; Fuh JL
    Geriatr Gerontol Int; 2020 Jan; 20(1):52-58. PubMed ID: 31773862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer's Disease.
    Horvath A; Quinlan P; Eckerström C; Åberg ND; Wallin A; Svensson J
    J Alzheimers Dis; 2024; 99(2):609-622. PubMed ID: 38701139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
    Low A; Ng KP; Chander RJ; Wong B; Kandiah N
    J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
    Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of age and apolipoprotein E ε4 status on regional white matter hyperintensity volume and cognition in healthy aging.
    Van Etten EJ; Bharadwaj PK; Grilli MD; Raichlen DA; Hishaw GA; Huentelman MJ; Trouard TP; Alexander GE
    J Int Neuropsychol Soc; 2024 Jul; 30(6):553-563. PubMed ID: 38515367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of regional white matter hyperintensity volume and apolipoprotein E ε4 status on hippocampal volume in healthy older adults.
    Van Etten EJ; Bharadwaj PK; Hishaw GA; Huentelman MJ; Trouard TP; Grilli MD; Alexander GE
    Hippocampus; 2021 May; 31(5):469-480. PubMed ID: 33586848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease.
    Chen YF; Wang H; Chu Y; Huang YC; Su MY
    Dement Geriatr Cogn Disord; 2006; 22(2):177-84. PubMed ID: 16912479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower vitamin D is associated with white matter hyperintensity in elderly women with Alzheimer's disease and amnestic mild cognitive impairment.
    Sakurai T; Ogama N; Toba K
    J Am Geriatr Soc; 2014 Oct; 62(10):1993-4. PubMed ID: 25333541
    [No Abstract]   [Full Text] [Related]  

  • 11. Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.
    Vipin A; Foo HJL; Lim JKW; Chander RJ; Yong TT; Ng ASL; Hameed S; Ting SKS; Zhou J; Kandiah N
    J Alzheimers Dis; 2018; 66(2):533-549. PubMed ID: 30320575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum cystatin C with white matter abnormalities in patients with amnestic mild cognitive impairment.
    Hirao K; Yamashita F; Tsugawa A; Haime R; Fukasawa R; Sato T; Okita M; Shimizu S; Kanetaka H; Umahara T; Sakurai H; Hanyu H
    Geriatr Gerontol Int; 2019 Oct; 19(10):1036-1040. PubMed ID: 31489777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment.
    Hirao K; Yamashita F; Tsugawa A; Haime R; Fukasawa R; Sato T; Kanetaka H; Umahara T; Sakurai H; Hanyu H; Shimizu S
    J Alzheimers Dis; 2021; 80(2):877-883. PubMed ID: 33579856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease.
    Ouma S; Suenaga M; Bölükbaşı Hatip FF; Hatip-Al-Khatib I; Tsuboi Y; Matsunaga Y
    Brain Behav; 2018 Mar; 8(3):e00936. PubMed ID: 29541546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role?
    Brickman AM; Schupf N; Manly JJ; Stern Y; Luchsinger JA; Provenzano FA; Narkhede A; Razlighi Q; Collins-Praino L; Artero S; Akbaraly TN; Ritchie K; Mayeux R; Portet F
    Alzheimers Dement; 2014 Nov; 10(6):619-29. PubMed ID: 25304991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study.
    Wang YL; Chen W; Cai WJ; Hu H; Xu W; Wang ZT; Cao XP; Tan L; Yu JT;
    J Alzheimers Dis; 2020; 73(2):759-768. PubMed ID: 31839612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative.
    Carmichael O; Schwarz C; Drucker D; Fletcher E; Harvey D; Beckett L; Jack CR; Weiner M; DeCarli C;
    Arch Neurol; 2010 Nov; 67(11):1370-8. PubMed ID: 21060014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated White Matter Hyperintensity Segmentation Using Bayesian Model Selection: Assessment and Correlations with Cognitive Change.
    Fiford CM; Sudre CH; Pemberton H; Walsh P; Manning E; Malone IB; Nicholas J; Bouvy WH; Carmichael OT; Biessels GJ; Cardoso MJ; Barnes J;
    Neuroinformatics; 2020 Jun; 18(3):429-449. PubMed ID: 32062817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of circulating vascular cell adhesion molecule-1 to white matter disintegrity in Alzheimer's dementia.
    Huang CW; Tsai MH; Chen NC; Chen WH; Lu YT; Lui CC; Chang YT; Chang WN; Chang AY; Chang CC
    Thromb Haemost; 2015 Nov; 114(6):1230-40. PubMed ID: 26289958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical and neuropsychological profiles of Alzheimer's disease with white matter hyperintensity in North China.
    Chen Y; Wang Y; Zhang M; Zhou Y; Zhang H; Li P; Wu J
    Front Neurol; 2024; 15():1436030. PubMed ID: 39416665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.